The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Effects of Pregnancy on CYP3A and P-glycoprotein Activities as Measured by Disposition of Midazolam and Digoxin: A University of Washington Specialized Center of Research Study
Abstract
The objectives of the study were to evaluate the effects of pregnancy on CYP3A and P-glycoprotein (P-gp) activities, as measured by disposition of midazolam and digoxin, respectively. Thirteen women received digoxin (0.25 mg p.o.) and midazolam (2 mg p.o.) in random order, separated by 1-2 weeks at 28-32 weeks gestation, and the same order was repeated at 6-10 weeks postpartum. Plasma and urine concentrations were determined by liquid chromatography-mass spectrometry and analyzed by noncompartmental methods. Midazolam CL/F(unbound) (593 +/- 237 l/min vs. 345 +/- 103 l/min; P = 0.007), digoxin CL(Renal, unbound) (272 +/- 45 ml/min vs. 183 +/- 37 ml/min; P < 0.002) and digoxin CL(secretion,) (unbound) (109 +/- 34 ml/min vs. 58 +/- 22 ml/min; P < 0.002) were higher during pregnancy than postpartum. These data are consistent with increased hepatic and/or intestinal CYP3A and renal P-gp activities during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin
Greiner, B., Eichelbaum, M., Fritz, P., Kreichgauer, H.-P., von Richter, O., Zundler, J., & Kroemer, H. K. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6663 · Cited by 917
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
Pregnancy-Induced Changes in Pharmacokinetics: A Mechanistic-Based Approach
Anderson, G. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544100-00001 · Cited by 648
Thummel, K. E., O'Shea, D., Paine, M. F., Shen, D. D., Kunze, K. L., Perkins, J. D., & Wilkinson, G. R. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90177-0 · Cited by 617
Self-citationOxidation of midazolam and triazolam by human liver cytochrome P450IIIA4.
Kronbach, T., Mathys, D., Umeno, M., Gonzalez, F. J., & Meyer, U. A. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09118-7 · Cited by 532
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancy
Tracy, T. S., Venkataramanan, R., Glover, D. D., & Caritis, S. N. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.08.030 · Cited by 448
Gorski, J. C., Jones, D. R., Haehner-Daniels, B. D., Hamman, M. A., O'Mara, E. M., & Hall, S. D. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90146-1 · Cited by 411
Isolation of a multispecific organic anion and cardiac glycoside transporter from rat brain
Noé, B., Hagenbuch, B., Stieger, B., & Meier, P. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10346 · Cited by 396
Christopher Gorski, J., Hall, S. D., Jones, D. R., & VandenBranden, M. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90543-6 · Cited by 395
Thummel, K. E., Shen, D. D., Podoll, T. D., Kunze, K. L., Trager, W. F., Hartwell, P. S., Raisys, V. A., Marsh, C. L., McVicar, J. P., & Barr, D. M. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22834-8 · Cited by 355
Self-citationTanigawara, Y., Okamura, N., Hirai, M., Yasuhara, M., Ueda, K., Kioka, N., Komano, T., & Hori, R. (1992) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10423-0 · Cited by 337
Mikkaichi, T., Suzuki, T., Onogawa, T., Tanemoto, M., Mizutamari, H., Okada, M., Chaki, T., Masuda, S., Tokui, T., Eto, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0304987101 · Cited by 289
Floyd, M. D., Gervasini, G., Masica, A. L., Mayo, G., George, A. L., Bhat, K., Kim, R. B., & Wilkinson, G. R. (2003) · Pharmacogenetics · doi:10.1097/00008571-200310000-00003 · Cited by 261
Gibbs, M. A., Thummel, K. E., Shen, D. D., & Kunze, K. L. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15274-9 · Cited by 245
Self-citationThummel, K. E., Shen, D. D., Podoll, T. D., Kunze, K. L., Trager, W. F., Bacchi, C. E., Marsh, C. L., McVicar, J. P., Barr, D. M., & Perkins, J. D. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22836-1 · Cited by 223
Self-citationDavison, J. M., & Noble, M. C. B. (1981) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1981.tb00930.x · Cited by 209
Itraconazole Decreases Renal Clearance of Digoxin
Jalava, K.-M., Partanen, J., & Neuvonen, P. J. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199712000-00001 · Cited by 176
Physiologic changes in pregnancy and their effect on drug disposition
Frederiksen, M. C. (2001) · Seminars in Perinatology · doi:10.1053/sper.2001.24565 · Cited by 171
P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans
Drescher, S., Glaeser, H., Mürdter, T., Hitzl, M., Eichelbaum, M., & Fromm, M. F. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.27 · Cited by 158
Pharmacokinetics of Antiretrovirals in Pregnant Women
Mirochnick, M. H., & Capparelli, E. V. (2004) · Clinical Pharmacokinetics · doi:10.2165/00003088-200443150-00002 · Cited by 153
Chiba, M., Hensleigh, M., Nishime, J. A., Balani, S. K., & Lin, J. H. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07348-9 · Cited by 146
24‐HOUR CREATININE CLEARANCE DURING THE THIRD TRIMESTER OF NORMAL PREGNANCY
Davison, J. M., Dunlop, W., & Ezimokhai, M. (1980) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1980.tb04501.x · Cited by 114
Comparison of midazolam and simvastatin as cytochrome P450 3A probes
CHUNG, E., Nafziger, A. N., Kazierad, D. J., & BERTINOJR, J. (2006) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.11.016 · Cited by 112
Lau, Y. Y., Wu, C., Okochi, H., & Benet, L. Z. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.061770 · Cited by 110
Expression of MDR1 (Multidrug Resistance) Gene and Its Protein in Normal Human Kidney
Ernest, S., Rajaraman, S., Megyesi, J. K., & Bello-Reuss, E. N. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000190289 · Cited by 107
Pharmacokinetics and Safety of Indinavir in Human Immunodeficiency Virus-Infected Pregnant Women
Unadkat, J. D., Wara, D. W., Hughes, M. D., Mathias, A. A., Holland, D. T., Paul, M. E., Connor, J. D., Huang, S., Nguyen, B., Watts, D. H., et al. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00420-06 · Cited by 82
Self-citationSmit, J. W., Schinkel, A. H., Müller, M. M., Weert, B., & Meijer, D. K. F. (1998) · Hepatology · doi:10.1002/hep.510270422 · Cited by 78
Pharmacokinetics of nelfinavir in HIV‐1‐infected pregnant and nonpregnant women
Villani, P., Floridia, M., Pirillo, M. F., Cusato, M. P., Tamburrini, E., Cavaliere, A. F., Guaraldi, G., Vanzini, C., Molinari, A., Antoni, A. D., et al. (2006) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2006.02669.x · Cited by 64
Woodahl, E. L., Yang, Z., Bui, T., Shen, D. D., & Ho, R. J. Y. (2005) · AIDS · doi:10.1097/01.aids.0000183626.74299.77 · Cited by 53
Sugiyama, D., Kusuhara, H., Shitara, Y., Abe, T., & Sugiyama, Y. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.2.220 · Cited by 46
Simultaneous Measurement of In Vivo P‐glycoprotein and Cytochrome P450 3A Activities
Kirby, B., Kharasch, E. D., Thummel, K. T., et al. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006292625 · Cited by 42
Self-citationPregnancy-Related Effects on Nelfinavir-M8 Pharmacokinetics: a Population Study with 133 Women
Hirt, D., Tréluyer, J., Jullien, V., Firtion, G., Chappuy, H., Rey, E., Pons, G., Mandelbrot, L., & Urien, S. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01596-05 · Cited by 41
Pharmacokinetics of clorazepate in pregnant and non-pregnant women
Rey, E., d'Athis, P., Giraux, P., Lauture, D. D., Turquais, J. M., Chavinie, J., & Olivé, G. (1979) · European Journal of Clinical Pharmacology · doi:10.1007/bf00563102 · Cited by 36
Cited by
Pharmacokinetics of drugs in pregnancy
Feghali, M., Venkataramanan, R., & Caritis, S. (2015) · Seminars in Perinatology · doi:10.1053/j.semperi.2015.08.003 · Cited by 375
Abduljalil, K., Furness, P., Johnson, T. N., Rostami-Hodjegan, A., & Soltani, H. (2012) · Clinical Pharmacokinetics · doi:10.2165/11597440-000000000-00000 · Cited by 371
Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review
Pariente, G., Leibson, T., Carls, A., Adams-Webber, T., Ito, S., & Koren, G. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1002160 · Cited by 336
Renal Transporters in Drug Development
Morrissey, K. M., Stocker, S. L., Wittwer, M. B., Xu, L., & Giacomini, K. M. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140317 · Cited by 324
Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Stillhart, C., Vučićević, K., Augustijns, P., Basit, A. W., Batchelor, H., Flanagan, T. R., Gesquiere, I., Greupink, R., Keszthelyi, D., Koskinen, M., et al. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105280 · Cited by 320
Metadata
- Authors
- Hebert, M., Easterling, T., Kirby, B., Carr, D., Buchanan, M., Rutherford, T., Thummel, K., Fishbein, D., & Unadkat, J.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2008-02-20
- Volume
- 84
- Issue
- 2
- Pages
- 248-253
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2008430084
- Cited by
- 259
- References
- 34
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.